image
Healthcare - Biotechnology - NASDAQ - US
$ 0.2718
4.18 %
$ 17.5 M
Market Cap
-0.46
P/E
INCOME STATEMENT
0 REVENUE
0.00%
-40 B OPERATING INCOME
-101845.46%
-37.9 B NET INCOME
-102555.16%
EFFICIENCY
Earnings Waterfall GlycoMimetics, Inc.
image
Revenue 0
Cost Of Revenue 0
Gross Profit 0
Operating Expenses 32.5 B
Operating Income -40 B
Other Expenses -2.16 B
Net Income -37.9 B

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 0 10 K 74.9 K 1.2 10.2 0 0 0 18 K 20.1 15.0 4.0 15.3 3.8
GROSS PROFIT
Cost Of Revenue 0 0 1.0 1.0 0 0.9 0.3 0.3 0 0 0 0 0 0
Gross Profit 0 10 K (1.0) 0.1 10.2 (0.9) (0.3) (0.3) 18 K 20.1 15.0 4.0 15.3 3.8
OPERATING INCOME
Operating Expenses 32 509.1 39.3 47.5 64.6 61.7 61.4 51.5 33.9 31.9 32.9 26.2 14.6 11.6 9.9
Selling, General and Administrative Expenses 18 249.3 19.2 19.1 17.1 16.7 14.4 11.4 9.8 8.7 7.8 6.6 2.9 2.2 2.1
Research and Development Expenses 14 259.8 20.1 28.4 47.5 44.9 47.0 40.1 24.1 23.3 25.1 19.6 11.7 9.4 7.8
Operating Income (40 039.4) (39.3) (47.4) (63.4) (51.5) (61.4) (51.5) (33.9) (31.9) (12.8) (11.1) (10.6) 3.7 (6.1)
PRE-TAX INCOME
Interest Income Expense 0 0 46.6 0 0 0 0 0 0 0 18 K 0.9 0 0
Total Other Income 0 2.4 0.7 19.8 K 0.5 3.5 3.2 0.7 0.1 15.3 K 18 K 894 21 K 28.4 K
Pre-Tax Income 0 (36.9) (46.7) (63.4) (51.0) (57.9) (48.3) (33.3) (31.8) (12.8) (11.1) (10.6) 3.7 (6.1)
NET INCOME
Tax Provision 0 637 46.6 (0.3) (0.8) (3.8) 3.2 0 (0.2) (0.2) (0.2) 894 21 K 8.39 K
Net Income 0 (36.9) (93.3) (63.1) (50.3) (54.1) (48.3) (33.3) (31.8) (12.8) (11.1) (10.6) 3.7 (6.1)
EPS 0.59 0.58 1.78 1.23 1.1 1.25 1.18 1.13 1.5 0.67 0.6 8.87 3.06 5.11